1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. World health organization histological classification of tumours of the central nervous system. Lyon: International Agency for Research on Cancer; 2016.
2. Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frenay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W. Guidelines management of low-grade gliomas: report of an EFNS-EANO task force. Eur J Neurol. 2010;17:1124–33.
3. Pedeutour-Braccini Z, Burel-Vandenbos F, Gozé C, Roger C, Bazin A, Costes-Martineau V, Duffau H, Rigau V. Microfoci of malignant progression in diffuse low-grade gliomas: towards the creation of an intermediate grade in glioma classification? Virshows Ach. 2015;466:433–44.
4. Mashiko R, Takano S, Ishikawa E, Yamamoto T, Nakai K, Matsumura A. Hypoxia-inducible factor 1alpha expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image. J Neuro-Oncol. 2011;102:43–50.
5. Bradac O, Vrana J, Jiru F, Kramar F, Netuka D, Hrabal P, Horinek D, de Lacy P, Benes V. Recognition of anaplastic foci within low- grade gliomas using MR spectroscopy. Br J Neurosurg. 2013;28(5):631–6.